RxDoctor Payments Data

Kelley Dilliard, DO

Family Medicine · Wausau, WINPI 1114411956

Payments from drug & device makers

$1,746in general payments, 2019–2025

Across 31 payments — averaging $56.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$650
  • Novo Nordisk$288
  • Exact Sciences$269
  • Lilly USA, LLC$125
  • Biohaven Pharmaceutical Holding Company Ltd.$121
  • Merck$116
  • plus $177 from 3 others

What the payments were for

  • Food & beverage$1,746100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,746 in reported general payments places this provider in the 90th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$40,621
Medicare patients
207
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban92$115,881
TrulicityDulaglutide68$71,761
JardianceEmpagliflozin42$59,037
OzempicSemaglutide28$39,118
RybelsusSemaglutide28$34,657
JanuviaSitagliptin Phosphate21$21,096
MounjaroTirzepatide19$20,425
Spiriva HandihalerTiotropium Bromide14$17,456
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$14,954
Advair HfaFluticasone Propion/Salmeterol12$6,485
DuleraMometasone/Formoterol16$5,264
Arnuity ElliptaFluticasone Furoate14$4,727
Levothyroxine Sodium369$3,980
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$3,759
Omeprazole301$3,621

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$115,88192 claims
Lilly USA, LLCTrulicity, Mounjaro$125$92,18687 claims
Novo NordiskOzempic, Rybelsus$288$73,77556 claims
Boehringer IngelheimJardiance$650$59,03742 claims
MerckJanuvia, Dulera$116$26,36037 claims
AbbVieSynthroid$15$2,43726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Wausau

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →